The FDA says certain Medtronic (NYSE:MDT) MiniMed 508 Paradigm insulin pumps have potential cybersecurity risks and advises patients to switch to better protected models.
Medtronic is recalling the affected MiniMed pumps and providing alternative insulin pumps to patients.
Check the FDA statement for the list of affected products.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.